INSIDE TRACK CONFERENCE
*Third party registration should be used if you are requesting an individual registration for someone who is not you.
Please note that website registration under your name will be needed before registering someone else to this event.
Chair: O. Pagani, CH
Scientific committee: F. Cardoso, PT - N. Harbeck, DE - S. Paluch-Shimon, IL - A. Partridge, US - F. Peccatori, IT - E. Senkus, PL - Y. Wengström, SE
Breast cancer in young women is a complex disease, occurring when these women are at the peak of their reproductive years, family life and careers. Being a somewhat rare disease the optimal management of these patients is based on scientific data derived from clinical trials mostly conducted on older women. Many aspects of breast cancer in young women are therefore poorly understood (e.g. etiology and biology among others) and research is much needed in this field. In addition, young women have many years ahead of them to suffer the long-term effects of treatment and specific survivorship issues (fertility and job among others). This fourth conference is a new opportunity for the latest updates on this field and a platform for generating future research concepts and collaborations. It will cover epidemiology, molecular biology, genetics, pathology, surgery, radiotherapy, systemic therapy, survivorship issues in young women with breast cancer.
It will also include a Consensus Session that will form the basis for a Consensus Guidelines manuscript to be published after the Conference.
• In depth learning and update of the scientific and clinical aspects of breast cancer in young women
• Highlight the importance of multi-disciplinary management and discuss difficult clinical cases
• Focus on clinical research priorities and future perspectives, involving patients’ advocates in setting the agenda
• Participate in the discussion of consensus guidelines
• Epidemiology of early and advanced disease
• Hereditary breast cancer
• Diagnostic tools and challenges
• Loco-regional therapy
• Systemic therapy
• Psychosocial aspects and survivorship
The Conference is an ESO-ESMO joint event.
O. Abulkhair, King Abdulaziz Medical City for National Guard, Riyadh, SA
H.A. Azim Jr., American University of Beirut, Beirut, LB
L. Baider, Sharett Institute of Oncology and Radiotherapy, Jerusalem, IL
G. Bianchi Micheli, Southern Switzerland Breast Center (CSSI), Viganello, Lugano, CH
S. Bober, Dana-Farber Cancer Institute, Boston, US
C. Canonica, Bellinzona and Valleys Regional Hospital, Bellinzona, CH
F. Cardoso, Champalimaud Clinical Center, Lisbon, PT
M.J. Cardoso, Champalimaud Clinical Center, Lisbon, PT
S. Cima, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, CH
R. Condorelli, Locarno Regional Hospital, Locarno, CH
M. Conti Beltraminelli, Italian Hospital, Viganello, Lugano, CH
G. Curigliano, European Institute of Oncology, Milan, IT
S. Di Lascio, Mendrisio Regional Hospital, Mendrisio, CH
N.S. El Saghir, American University of Beirut Medical Center, Beirut, LB
P. Fox, University College Dublin, Dublin, IE
J. Garber, Dana Farber Cancer Institute Boston, US
K. Gelmon, BC Cancer Agency, Vancouver, CA
A. Gorini, Milan University, Milan, IT
R. Graffeo, Oncology Institute of Southern Switzerland (IOSI), Lugano, CH
S. Han, UZ Leuven, Lauven, BE
N. Harbeck, University of Munich (LMU), Munich, DE
B. Kaufman, Sheba Medical Center, Ramat Gan, IL
M. Lambertini, Institut Jules Bordet, Brussels, BE
K. Lång, Lund University, Malmö, SE
F. Meani, Lugano Regional Hospital, Lugano, CH
J. Merschdorf, Young Survival Coalition, New York, US
O. Pagani, Oncology Institute of Southern Switzerland (IOSI), Bellizona, CH
S. Paluch-Shimon, Shani Shaare Zedek Medical Centre, Jerusalem, IL
A.H. Partridge, Dana-Farber Cancer Institute, Boston, US
F.A. Peccatori, European Institute of Oncology, Milan, IT
P. Poortmans, Institut Curie, Paris, FR
G. Pravettoni, European Institute of Oncology, Milan, IT
G. Pruneri, National Cancer Institute - Foundation IRCCS, Milan, IT
A. Richetti, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, CH
A. Santi, Locarno Regional Hospital, Locarno, CH
E. Senkus, Medical University of Gdansk, Gdansk, PL
T. Spanic, Europa Donna Slovenia, Ljubljana, SI
M. Taborelli, Italian Hospital, Viganello, Lugano, CH
M. Valli, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, CH
I. Vaz-Luis, Gustave Roussy Institute, Villejuif, FR
V.A. Vitale, Southern Switzerland Breast Center (CSSI), Viganello, Lugano, CH
Y. Wengström, Karolinska University Hospital, Huddinge, SE
J. Winterling, Karolinska University Hospital, Stockholm, SE
S. Zehbe, Bellinzona and Valleys Regional Hospital, Bellinzona, CH
S. Zuckerman, Shaare Zedek Medical Center, Jerusalem, IL
Organisation and Programme
Francesca Marangoni (1)
phone: +39 02 85464525
Registrations and Abstracts
Alice Ciocchini (1)
phone: +39 02 85464529
Sponsorship and travel grants
Luis Carvalho (2)
phone: +41 91 8200958
(1) European School of Oncology, Via Turati 29, 20123 Milan, Italy
(2) European School of Oncology, Piazza Indipendenza 2, 6500 Bellinzona, Switzerland
Palazzo dei Congressi Lugano
Piazza Indipendenza 4
The official language will be English. No translation will be provided.
The organisers bear no responsibility for ontoward events in relation to the participation in the Conference. Participants are advised to take out their own personal and travel insurance coverage.
An abstract book will be published as supplement to The Breast and will contain abstracts of the invited lecturers and those submitted by the participants that have been accepted for oral or poster presentation or for publication only. The best abstract will be selected and proposed for oral presentation (Free registration will be granted to the first author of the selected abstract). Oral presentation will be scheduled on 8 October while poster session will be scheduled on 7 October.
CME ACCREDITATION CERTIFICATES
Participants will be issued a certificate of attendance. Application for CME recognition will be submitted to the Accreditation Council of Oncology in Europe (ACOE) and to the European Accreditation Council for Continuing Medical Education (EACCME), an institution of the European Union of Medical Specialists (UEMS). EACCME credits are recognised by the American Medical Association towards the Physician’s Recognition Award (PRA).
Information on the status of the applications can be obtained from the organising secretariat.
ESMO-MORA credits will be granted by ESMO.
Travel grants are made available on a competitive basis.
ESO is particularly grateful to The Breast Cancer Research Foundation for having provided grants to support the participation of several participants.
For further information, please contact Luis Carvalho (firstname.lastname@example.org)
SPONSORED SATELLITE SYMPOSIA
6 October 2018, 18:00 - Roche satellite symposium
7 October 2018, 18:10 - Ipsen satellite symposium
BCY CONFERENCE AND CONSENSUS GUIDELINES
Breast Cancer in Young Women Conference (BCY1)
8-10 November 2012
The guidelines are published in The Breast 23 (2014) 209-220
2nd Breast Cancer in Young Women Conference (BCY2)
4-5 November 2014
The guidelines are published in The Breast 26 (2016) 87-99
3rd ESO-ESMO Breast Cancer in Young Women International Conference (BCY3)
10-12 November 2016
The guidelines are published in The Breast 26 (2017), Volume 35, pages 203–217
Session 5 on Fertility and Pregnancy is supported by Dana-Farber Cancer Institute while the Nursing session is held in collaboration with EONS.
ESO wishes to express its appreciation to the following sponsors for having granted their participation and support to BCY4:
|Early registration by:||17 June 2018|
|Late registration by:||23 September 2018|
|Save event date:||06 October 2018|
• Medical oncologists
• Radiation oncologists
• Breast radiologists
• Patient advocates
Registration may be carried out online (available at the top of this page) or by returning the registration form.
Registration includes participation in all sessions, a copy of the Programme and the Abstract Book, coffee breaks and lunch as indicated in the programme.
* BreastCentresNetwork, Club ESO and ESMO Members
• Registration to the Patient Advocates workshop only: 50€
CANCELLATION OF REGISTRATION OR REPLACEMENT
(applicable only for individual registrations)
Cancellation should be notified to ESO in writing. In case of cancellation without replacement, the fee less handling charges of EUR 100 will be refunded within two months from notification, provided that the cancellation is received by ESO before 14 September 2018. Replacements will be possible till 23 September 2018.
CONFIRMATION OF REGISTRATION
Registration will be confirmed by e-mail.
The badge is the only official evidence of registration and should be worn at all times during the event. Loss of badge causes loss of registration.
NURSES AND PATIENT ADVOCATES
Nurses and representatives of cancer patient advocacy non-profit organizations are eligible for a discounted registration fee:
EUR 200 by 17 June, EUR 250 by 23 September, EUR 300 from 24 September and onsite.
Interested nurses and patient advocates should register online and then provide the requested documents by email to Alice Ciocchini (email@example.com) within one week, in order to complete the registration. Should we not receive the documents within the deadline, the registration will not be confirmed.
Requested documents are:
• Nurses: please provide your curriculum vitae with full contact details.
• Patient advocates: please provide your curriculum vitae or resume indicating your advocacy experience, role within the organisation and the full contact details of the patient advocate organisation.
Patient Advocates registration to the BCY4 conference includes participation in the Patient Advocates workshop scheduled on 8 October from 14.00 to 18.30.
It is nevertheless possibile for interested Patient Advocates to paticipate in the metioned workshop only. Registration to the workshop is requested and the cost is 50€ (lunch and coffee break included). For further details and registration, please contact Alice Ciocchini (firstname.lastname@example.org).
The conference is open to representatives of print and electronic media. Registration is free of charge to journalists who are in possession of a valid, recognised press card. Freelance journalists must present a commissioning letter on headed paper from a recognised news organisation or publication. Representatives of advertising, marketing and public relations companies are not eligible for free media registration. A copy of the Press Card or of the commissioning letter should be sent, together with the media registration form, to Alice Ciocchini (email@example.com).
Group registration may be processed online for groups of 5 or more individuals and is available at the bottom of this page. Further instructions can also be found here.
For hotel accommodation in Lugano, please book online at http://bit.ly/2z0GLxo
| OPENING SESSION Chair: O. Pagani, CH
|12:00||Welcome by Cantonal Authorities|
|12:15||KEYNOTE 1: Presentation by young patient|
|12:30||KEYNOTE 2: Treating breast cancer in different ethnic populations
L. Baider, IL
|SESSION 1: TUMOR BIOLOGY
Chair: G. Pruneri, IT
|13:00||Clinical utility of RNA and DNA gene expression tests in young women with early and advanced disease
H.A. Azim Jr., LB
|SESSION 2: FAMILIAL AND HEREDITARY BREAST CANCER
Chairs: R. Graffeo, CH - M. Taborelli, CH
|13:20||Clinical management of women harboring low-moderate risk genes: any guideline?
J. Garber, US
|13:40||Systemic therapies in BRCA+ breast cancer - what's new?
S. Paluch-Shimon, IL
|14:00||Ethical dilemmas around genetic testing
S. Zuckerman, IL
|SESSION 3: NEOADJUVANT THERAPIES AND LOCO-REGIONAL TREATMENT
Chairs: A. Richetti, IT - V. Arcangelo Vitale, IT
|15:10||Indications to neoadjuvant chemotherapy and tailored strategies
N. Harbeck, DE
|15:30||Challenges for the radiologist
K. Lång, SE
|15:45||Challenges for the onco-plastic surgeon
M.J. Cardoso, PT
|16:05||Challenges for the pathologist
|16:20||Challenges for the radiation oncologist
P. Poortmans, FR
|NURSING SESSION: SUPPORTIVE CARE - REHABILITATION
(held in collaboration with EONS)
Chair: Y. Wengström, SE
Y. Wengström, SE
|17:05||Supportive care - rehabilitation
J.e Winterling, SE
|17:25||Physical activity during treatment for breast cancer
Y. Wengström, SE
|18:00||Satellite symposium 1|
|8:30||PATIENT ADVOCATE AGENDA
Chairs: J. Merschdorf, US - T. Spanic, SI
|SESSION 4: SYSTEMIC THERAPIES
Chairs: M. Conti Beltraminelli, CH - O. Abulkhair, SA
|9:15||News in adjuvant therapy of HR+ disease
O. Pagani, CH
|9:30||News in adjuvant therapy of triple negative and HER2+ disease
G. Curigliano, IT
|9:45||News in the management of ABC
F. Cardoso, PT
|10:00||Treatment adherence: any real impact on outcomes?
B. Kaufman, IL
|10:15||Long-term side effects: the wolf in the cage
I. Vaz-Luis, FR
|10:40||Magnitude of clinical benefit: anything different in young women?
E. Senkus, PL
|SESSION 5: FERTILITY AND PREGNANCY
(session supported by Dana-Farber Cancer Institute)
Chairs: A. Santi, CH - C. Canonica, CH
|11:30||Pregnancy during breast cancer: any news?
S. Han, BE
|11:45||Sexual life after breast cancer
S. Bober, US
|12:05||Maternity after breast cancer
F.A. Peccatori, IT
|12:25||Physicians attitudes and knowledge about fertility preservation
M. Lambertini, IT
|12:55||Research priorities: summary of BCYR1
A.H. Partridge, US
|13:05||Lunch and poster session|
|SESSION 6: ROUNDTABLE - MINORITY REPORTS: THE PATIENTS’ VOICE
Chairs: K. Gelmon, CA - S. Paluch-Shimon, IL
|SESSION 7: FOLLOW-UP CARE
Chairs: F.A. Peccatori, IT - Y. Wengström, SE
|15:00||Follow-up clinics: nurses to lead them?
Y. Wengström, SE
|15:20||Remote programs for follow-up
P. Fox, IE
|15:40||Return to work: hope or reality?
A. Gorini, IT
|SESSION 8: SURVIVORSHIP AND QUALITY OF LIFE ISSUES
Chairs: A.H. Partridge, US - S. Di Lascio, CH
|16:50||Support groups in the post treatment phase
G. Bianchi Micheli, CH
|17:10||Supporting children, partners and relatives
G. Pravettoni, IT
|17:30||Access to care (including fertility preservation)
N.S. El Saghir, LB
|18:10||Satellite symposium 2|
|SESSION 9: CASE DISCUSSION|
|8:30||Case Discussion - early breast cancer
Chairs: R. Condorelli, CH - M. Valli, CH - F. Meani, CH
|9:15||Case Discussion - advanced breast cancer
Chairs: K. Gelmon, CA - P. Poortmans, FR - S. Zehbe, CH
|10:00||Best abstract presentation
Chair: S. Cima, CH
|10:40||Summary statement on behalf of the Young Women Advocates|
|10:50||SESSION 10: BREAST CANCER IN YOUNG WOMEN INTERNATIONAL CONFERENCE STATEMENTS
Panelists: O. Abulkhair, SA - H.A. Azim Jr., LB - G. Bianchi Micheli, CH - F. Cardoso, PT - M.J. Cardoso, PT - J. Garber, US - K. Gelmon, CA - N. Harbeck, DE - J. Merschdorf, US - O. Pagani, CH - S. Paluch-Shimon, IL - A.H. Partridge, US - F.A. Peccatori, IT - P. Poortmans, FR - G. Pruneri, IT - E. Senkus, PL - T. Spanic, SI - Y. Wengström, SE
|13:00||Close of the BCY4 conference
|WORKSHOP for Patient Advocates: What Advocates should know about breast cancer in young women (Wrap up session in collaboration with Europa Donna and the Young Survival Coalition)|
|14:15||Principles of genetic predisposition and counselling|
|14:35||How to interpret the pathology report|
|14:50||Principles of surgery|
|15:10||Principles of radiation therapy|
|15:30||Principles of systemic therapies in early breast cancer andmanagement of early and late treatment side effects|
|16:00||Questions and answers|
|17:00||Principles of systemic the rapies in advanced breast cancer andthe Global Alliance project|
|17:30||The importance of multidisciplinary care|
|17:45||Principles of clinical research|
|18:00||Questions and answers|